PDS Biotechnology Corporation (PDSB)
NASDAQ: PDSB · Real-Time Price · USD
2.101
+0.076 (3.73%)
Nov 21, 2024, 2:28 PM EST - Market open
PDS Biotechnology Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 77 | 155 | 376 | 230 | 48 | 14 | |
| Market Cap Growth | -9.77% | -58.92% | 63.37% | 383.52% | 240.40% | - | |
| Enterprise Value | 41 | 124 | 328 | 161 | 15 | -3 | |
| Last Close Price | 2.02 | 4.97 | 13.20 | 8.10 | 2.14 | 2.65 | |
| PB Ratio | 2.41 | 5.92 | 8.55 | 3.64 | 1.76 | 1.20 | |
| P/TBV Ratio | 4.55 | 5.92 | 8.55 | 3.64 | 1.76 | 1.20 | |
| Debt / Equity Ratio | 0.79 | 0.91 | 0.53 | 0.01 | 0.02 | - | |
| Quick Ratio | - | 4.15 | 7.52 | 17.37 | 8.82 | 4.35 | |
| Current Ratio | - | 4.33 | 7.79 | 17.80 | 9.28 | 5.18 | |
| Return on Equity (ROE) | - | -122.46% | -76.21% | -37.46% | -76.48% | -145.33% | |
| Return on Assets (ROA) | - | -39.45% | -36.12% | -27.32% | -41.05% | -145.69% | |
| Return on Capital (ROIC) | -47.60% | -45.81% | -39.71% | -29.31% | -47.23% | -221.00% | |
| Earnings Yield | -51.92% | -27.78% | -10.86% | -7.34% | -31.17% | -50.01% | |
| FCF Yield | -21.76% | -6.83% | -5.42% | -27.60% | -129.14% | |
| Buyback Yield / Dilution | -15.51% | -8.23% | -11.73% | -52.86% | -243.98% | -45.87% | |
| Total Shareholder Return | -15.51% | -8.23% | -11.73% | -52.86% | -243.98% | -45.87% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.